Semaglutide vs tirzepatide vs retatrutide — how do their mechanisms actually differ?

These get lumped together as "GLP-1s" but they hit different receptors — single agonist, dual GIP/GLP-1, and triple-agonist respectively. Can anyone break down what those receptor differences mean in practical and physiological terms? Cited sources welcome.